tiprankstipranks
Cellectar Biosciences (CLRB)
NASDAQ:CLRB

Cellectar Biosciences (CLRB) Financial Statements

1,204 Followers

Cellectar Biosciences Financial Overview

Cellectar Biosciences's market cap is currently ―. The company's EPS TTM is $-3.106; its P/E ratio is -1.17; Cellectar Biosciences is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -8.22M$ -8.58M$ -7.42M$ -7.82M$ -7.44M
EBITDA$ -8.18M$ -8.54M$ -7.38M$ -7.78M$ -7.40M
Net Income Common Stockholders$ -8.22M$ -8.58M$ -7.22M$ -7.81M$ -7.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.15M$ 12.68M$ 19.87M$ 17.79M$ 24.81M
Total Assets$ 6.51M$ 14.84M$ 21.59M$ 19.32M$ 25.89M
Total Debt$ 584.50K$ 599.45K$ 603.83K$ 201.97K$ 236.06K
Net Debt$ -4.57M$ -12.08M$ -19.26M$ -17.58M$ -24.57M
Total Liabilities$ 6.98M$ 7.50M$ 6.08M$ 6.57M$ 5.70M
Stockholders Equity$ -467.00K$ 7.33M$ 15.51M$ 12.75M$ 20.19M
Cash Flow-
Free Cash Flow$ -7.53M$ -7.18M$ -7.53M$ -7.02M$ -5.83M
Operating Cash Flow$ -7.53M$ -7.18M$ -7.41M$ -7.01M$ -5.76M
Investing Cash Flow--$ -117.86K$ -7.07K$ -70.98K
Financing Cash Flow-$ 3.00$ 9.61M$ 0.00$ 0.00
Currency in USD

Cellectar Biosciences Earnings and Revenue History

Cellectar Biosciences Debt to Assets

Cellectar Biosciences Cash Flow

Cellectar Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis